We exist to improve the lives
of everyone affected by epilepsy

US authorities approve Lamictal for children

29 January, 2003

The US Food and Drug Administration (FDA) has approved the use of the drug Lamictal (lamotrigine) as an 'add-on' drug for children over the age of two with partial seizures.

According to the manufacturers, GlaxoSmithKline, the licence was granted following a study of 199 patients in which 42 per cent of those treated with Lamictal experienced more than 50 per cent reduction in the number of seizures, compared to 16 per cent who took a placebo.

The lead author of the study, Dr Michael Duchowny, said that another benefit of the medication was that few children in the trial suffered side effects.

Lamictal was previously only licensed in the USA for adults with partial seizures and children with Lennox-Gastaut syndrome.